The global diagnostic imaging market was valued at $27,930.5 million in 2015, and it is expected to grow at a CAGR of 4.9% during 2016-2022. Based on type of diagnostic imaging, the x-ray imaging segment dominated the global market in 2015.
The global diagnostic imaging market is growing at a significant rate, due to increasing healthcare expenditure, increasing awareness of early diagnosis, and growing geriatric population. The increasing prevalence of chronic diseases, technological advancement and widening application of diagnostic imaging devices, and improving healthcare infrastructure in developing countries are also driving the growth of the global diagnostic imaging market.
Diagnostic imaging is a technique and process used to create image of the internal as well as external human body parts for clinical purpose. X-ray, ultrasound, magnetic resonance imaging, computed tomography, single photon emission tomography (SPECT), and positron emission tomography (PET), are some of the major diagnostic imaging techniques.
The factors, such as stringent regulatory requirements, increasing risk of cancer due to exposure of radiation, and shortage of helium gas deposits for magnetic resonance imaging are inhibiting the growth of the global market.
Geographically, North America dominated the global market of diagnostic imaging in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth at a CAGR of 5.7%, during the forecast period.
Some of the key companies operating in the global diagnostic imaging market include Siemens AG, Koninklijke Philips N.V., General Electric Company, Hitachi Ltd., Toshiba Corporation, Shimadzu Corporation, FUJIFILM Holdings Corporation, SAMSUNG, and Esaote SpA.
News Courtesy: P&S Market Research